These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27994103)

  • 1. Development of Immunoassays for
    Nualnoi T; Norris MH; Tuanyok A; Brett PJ; Burtnick MN; Keim PS; Settles EW; Allender CJ; AuCoin DP
    Am J Trop Med Hyg; 2017 Feb; 96(2):358-367. PubMed ID: 27994103
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs.
    Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC
    Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
    Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
    Anuntagool N; Sirisinha S
    Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of
    Burtnick MN; Dance DAB; Vongsouvath M; Newton PN; Dittrich S; Sendouangphachanh A; Woods K; Davong V; Kenna DTD; Saiprom N; Sengyee S; Hantrakun V; Wuthiekanun V; Limmathurotsakul D; Chantratita N; Brett PJ
    Microbiol Spectr; 2024 Mar; 12(3):e0332123. PubMed ID: 38299821
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins.
    Jones SM; Ellis JF; Russell P; Griffin KF; Oyston PCF
    J Med Microbiol; 2002 Dec; 51(12):1055-1062. PubMed ID: 12466403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.
    Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL
    Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serodiagnosis of melioidosis by a competitive enzyme-linked immunosorbent assay using a lipopolysaccharide-specific monoclonal antibody.
    Thepthai C; Smithtikarn S; Suksuwan M; Songsivilai S; Dharakul T
    Asian Pac J Allergy Immunol; 2005; 23(2-3):127-32. PubMed ID: 16252843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis.
    Houghton RL; Reed DE; Hubbard MA; Dillon MJ; Chen H; Currie BJ; Mayo M; Sarovich DS; Theobald V; Limmathurotsakul D; Wongsuvan G; Chantratita N; Peacock SJ; Hoffmaster AR; Duval B; Brett PJ; Burtnick MN; Aucoin DP
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2727. PubMed ID: 24651568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification of Burkholderia pseudomallei in blood cultures by latex agglutination using lipopolysaccharide-specific monoclonal antibody.
    Dharakul T; Songsivilai S; Smithikarn S; Thepthai C; Leelaporn A
    Am J Trop Med Hyg; 1999 Oct; 61(4):658-62. PubMed ID: 10548306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei and taxonomically closely related nonfermenters.
    Iihara H; Niwa T; Shah MM; Nhung PH; Song SX; Hayashi M; Ohkusa K; Itoh Y; Makino S; Ezaki T
    Jpn J Infect Dis; 2007 Jul; 60(4):230-4. PubMed ID: 17642542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.
    Zhang S; Feng SH; Li B; Kim HY; Rodriguez J; Tsai S; Lo SC
    Clin Vaccine Immunol; 2011 May; 18(5):825-34. PubMed ID: 21450976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.
    AuCoin DP; Reed DE; Marlenee NL; Bowen RA; Thorkildson P; Judy BM; Torres AG; Kozel TR
    PLoS One; 2012; 7(4):e35386. PubMed ID: 22530013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
    J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid identification of Burkholderia pseudomallei in blood cultures by a monoclonal antibody assay.
    Pongsunk S; Thirawattanasuk N; Piyasangthong N; Ekpo P
    J Clin Microbiol; 1999 Nov; 37(11):3662-7. PubMed ID: 10523570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing the environmental footprint of the Burkholderia pseudomallei lipopolysaccharide genotypes in the tropical "Top End" of the Northern Territory, Australia.
    Webb JR; Rachlin A; Rigas V; Sarovich DS; Price EP; Kaestli M; Ward LM; Mayo M; Currie BJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007369. PubMed ID: 31348781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid A structure and TLR4-dependent innate immune activation.
    Sengyee S; Yoon SH; Paksanont S; Yimthin T; Wuthiekanun V; Limmathurotsakul D; West TE; Ernst RK; Chantratita N
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006287. PubMed ID: 29474381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharides from Different
    Sengyee S; Yoon SH; West TE; Ernst RK; Chantratita N
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei.
    Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC
    Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.